ResearcherInstitute of Cancer ResearchNo recent work listed
Theodore Evan
Matched on ORCID iD 0000-0002-8326-900X; OpenAlex author ID A5044485442. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2019: 1 paper · 2020: none · 2021: none · 2022: 3 papers
Papers 4
- The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-022-02448-x↗
- USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer. Co-author DOI 10.1038/s41467-022-29684-9↗
- GREM1 is required to maintain cellular heterogeneity in pancreatic cancer. First author DOI 10.1038/s41586-022-04888-7↗
- CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth. Co-author DOI 10.1038/s41556-019-0407-1↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Axel Behrens · 4 shared papers, 2019–2022 · strength 0.58
- Paper The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-022-02448-x↗
- Paper USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic ca… DOI 10.1038/s41467-022-29684-9↗
- Paper GREM1 is required to maintain cellular heterogeneity in pancreatic cancer. DOI 10.1038/s41586-022-04888-7↗
- Victoria M.-Y. Wang · 2 shared papers, 2019–2022 · strength 0.34
- Jessica Kristine Nelson · 2 shared papers, 2022 · strength 0.24
- Yoh Zen · 2 shared papers, 2022 · strength 0.24
- Andreas A. Prachalias · 1 shared paper, 2022 · strength 0.12
- Debashis Sarker · 1 shared paper, 2022 · strength 0.12
- Anguraj Sadanandam · 1 shared paper, 2022 · strength 0.12
- Linxiang Lan · 1 shared paper, 2022 · strength 0.12
- Huafu Li · 1 shared paper, 2022 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.